エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 5,799 | 5,819 | 5,670 | 5,670 | -138 | -2.4% | 1,208,900 |
| 2022/03/30 | 5,899 | 5,906 | 5,772 | 5,808 | -97 | -1.6% | 760,500 |
| 2022/03/29 | 5,893 | 5,906 | 5,851 | 5,905 | +12 | +0.2% | 1,138,600 |
| 2022/03/28 | 5,974 | 5,974 | 5,883 | 5,893 | -74 | -1.2% | 530,600 |
| 2022/03/25 | 5,941 | 5,967 | 5,883 | 5,967 | +29 | +0.5% | 600,800 |
| 2022/03/24 | 5,977 | 5,999 | 5,865 | 5,938 | -74 | -1.2% | 754,700 |
| 2022/03/23 | 5,950 | 6,022 | 5,949 | 6,012 | +142 | +2.4% | 763,100 |
| 2022/03/22 | 5,958 | 5,958 | 5,851 | 5,870 | +12 | +0.2% | 700,600 |
| 2022/03/18 | 5,872 | 5,899 | 5,798 | 5,858 | +31 | +0.5% | 858,300 |
| 2022/03/17 | 5,808 | 5,835 | 5,706 | 5,827 | +142 | +2.5% | 807,300 |
| 2022/03/16 | 5,770 | 5,810 | 5,675 | 5,685 | -55 | -1% | 1,148,600 |
| 2022/03/15 | 5,605 | 5,771 | 5,600 | 5,740 | +131 | +2.3% | 717,600 |
| 2022/03/14 | 5,527 | 5,686 | 5,525 | 5,609 | +141 | +2.6% | 977,400 |
| 2022/03/11 | 5,562 | 5,582 | 5,442 | 5,468 | -122 | -2.2% | 1,052,300 |
| 2022/03/10 | 5,553 | 5,596 | 5,485 | 5,590 | +137 | +2.5% | 1,370,500 |
| 2022/03/09 | 5,584 | 5,593 | 5,451 | 5,453 | -130 | -2.3% | 1,215,300 |
| 2022/03/08 | 5,579 | 5,679 | 5,557 | 5,583 | +2 | ±0% | 905,700 |
| 2022/03/07 | 5,630 | 5,636 | 5,517 | 5,581 | -112 | -2% | 1,077,900 |
| 2022/03/04 | 5,751 | 5,768 | 5,635 | 5,693 | -25 | -0.4% | 923,600 |
| 2022/03/03 | 5,733 | 5,740 | 5,685 | 5,718 | +21 | +0.4% | 430,900 |
| 2022/03/02 | 5,728 | 5,749 | 5,664 | 5,697 | -80 | -1.4% | 643,700 |
| 2022/03/01 | 5,767 | 5,826 | 5,757 | 5,777 | +59 | +1% | 806,800 |
| 2022/02/28 | 5,694 | 5,732 | 5,658 | 5,718 | +22 | +0.4% | 784,200 |
| 2022/02/25 | 5,657 | 5,697 | 5,619 | 5,696 | +72 | +1.3% | 606,500 |
| 2022/02/24 | 5,640 | 5,686 | 5,572 | 5,624 | -41 | -0.7% | 1,065,900 |
| 2022/02/22 | 5,750 | 5,754 | 5,625 | 5,665 | -108 | -1.9% | 885,100 |
| 2022/02/21 | 5,806 | 5,816 | 5,748 | 5,773 | -133 | -2.3% | 739,300 |
| 2022/02/18 | 5,851 | 5,955 | 5,851 | 5,906 | -1 | ±0% | 557,000 |
| 2022/02/17 | 5,921 | 5,932 | 5,830 | 5,907 | -24 | -0.4% | 574,300 |
| 2022/02/16 | 5,943 | 5,951 | 5,873 | 5,931 | +76 | +1.3% | 624,000 |
| 2022/02/15 | 5,885 | 5,928 | 5,807 | 5,855 | +63 | +1.1% | 681,400 |
| 2022/02/14 | 5,900 | 5,900 | 5,758 | 5,792 | -173 | -2.9% | 973,000 |
| 2022/02/10 | 5,896 | 5,970 | 5,895 | 5,965 | +85 | +1.4% | 888,600 |
| 2022/02/09 | 5,849 | 5,899 | 5,816 | 5,880 | +38 | +0.7% | 813,600 |
| 2022/02/08 | 5,821 | 5,922 | 5,812 | 5,842 | +90 | +1.6% | 746,500 |
| 2022/02/07 | 5,762 | 5,814 | 5,712 | 5,752 | -5 | -0.1% | 811,300 |
| 2022/02/04 | 5,770 | 5,791 | 5,650 | 5,757 | -35 | -0.6% | 1,362,300 |
| 2022/02/03 | 5,825 | 5,888 | 5,770 | 5,792 | -90 | -1.5% | 1,159,500 |
| 2022/02/02 | 5,815 | 5,917 | 5,788 | 5,882 | +143 | +2.5% | 1,158,500 |
| 2022/02/01 | 5,791 | 5,798 | 5,707 | 5,739 | -40 | -0.7% | 902,300 |
| 2022/01/31 | 5,794 | 5,800 | 5,725 | 5,779 | -23 | -0.4% | 1,003,600 |
| 2022/01/28 | 5,747 | 5,819 | 5,747 | 5,802 | +79 | +1.4% | 892,000 |
| 2022/01/27 | 5,928 | 5,942 | 5,665 | 5,723 | -179 | -3% | 1,244,800 |
| 2022/01/26 | 5,933 | 5,935 | 5,818 | 5,902 | +9 | +0.2% | 712,700 |
| 2022/01/25 | 5,955 | 5,971 | 5,866 | 5,893 | -155 | -2.6% | 1,179,700 |
| 2022/01/24 | 5,898 | 6,061 | 5,881 | 6,048 | +114 | +1.9% | 848,500 |
| 2022/01/21 | 5,933 | 5,952 | 5,862 | 5,934 | -62 | -1% | 1,216,700 |
| 2022/01/20 | 6,017 | 6,064 | 5,942 | 5,996 | +15 | +0.3% | 1,084,200 |
| 2022/01/19 | 6,002 | 6,055 | 5,953 | 5,981 | -92 | -1.5% | 1,281,500 |
| 2022/01/18 | 6,156 | 6,174 | 6,038 | 6,073 | -82 | -1.3% | 1,023,000 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
